Global Tissue Imaging Market Research Report: Forecast (2025-2030)

Market Definition

Tissue imaging is a medical technique that offers images of tissues and determines their properties through spectroscopic measurements. It quantifies adipose tissues, skeletal muscle, edema, and visceral organs for clinical analysis and medical intervention.

Market Insights & Analysis: Global Tissue Imaging Market (2025-30):

The Global Tissue Imaging Market size was valued at USD 10.3 billion in 2023 and is projected to reach USD 14.3 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9.50% during the forecast period, i.e., 2025-30.

The rates of cancer, CVDs, and numerous chronic diseases have been significant globally. Patients with these conditions require early and accurate diagnosis to confirm the presence of diseases and proceed with appropriate treatment. The World Health Organization (WHO) reported 20 million new cases of cancer, globally in 2022. Also, the cases are expected to rise to 32.6 million by 2045. Consequently, there has been an increased demand for various tissue imaging products such as Microscopes, Flow Cytometry Analyzers, etc.

Also, infectious diseases like tuberculosis & HIV have been affecting many, whereas others like COVID & Ebola have spread to take the form of pandemics & epidemics. This motivated the researchers to initiate research programs for studying disease pathology, understanding causative agents, and other essential aspects to avoid such instances soon. Due to this the adoption of Tissue Imaging products has experienced a rise in demand. 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Also, obesity is rising at an astronomical pace throughout the world due to urbanization and unhealthy eating habits. This has led to a rise in lifestyle-related diseases such as CVDs & diabetes. As a result, there has been a growing demand for tissue imaging techniques as more individuals seek early diagnosis at hospitals & diagnostic centers. For instance,

• The WHO stated that in 2022 about 2.5 billion adults aged between 18 years & over were overweight. Out of these, 890 million people were living with obesity.

Further, there are awareness programs such as the Let's Stop HIV Together (Together) campaign & Talk Cancer Training Programme led by governments & non-government bodies across countries to promote early disease diagnosis and management. These programs especially for diseases like cancer, tuberculosis, HIV, and others have motivated individuals who are at risk due to factors such as smoking, alcohol consumption, poor diet, lack of physical activity, and family history to visit healthcare facilities for appropriate examinations and testing. In addition to this, the doctor's recommendation for annual tests for diseases like prostate cancer & breast cancer has supported the Global Market for Tissue Imaging. Additionally, there has been a growing popularity of digital pathology due to its ability to facilitate remote consultations, thereby improving access to specialized pathology services, especially in underserved & remote areas.

Global Tissue Imaging Market Driver:

Inclination Towards Precision Medicine to Drive the Global Tissue Imaging Market– Globally, the cases of cancer & neurological diseases are on the rise. However, current treatment methods, based on a one-size-fits-all approach, have not been very effective or beneficial to every patient suffering from these conditions. In addition, certain treatments have had negative impacts on the patients' health.

As a result, the focus has shifted to the research and development of therapies tailored to the patient’s genetics, environment, and lifestyle factors. These have greater efficacy, benefits, and minimal side effects than conventional treatments. This shifted focus has led to the adoption of tissue imaging technologies, which provide researchers with detailed visualizations and analyses of cellular and molecular structures. The information enables them to develop effective personalized treatments.

Furthermore, increased investments and funding by governments of different nations and private pharmaceutical companies to encourage research on personalized medicine have propelled the adoption of tissue imaging techniques. As a result, the market size for Tissue Imaging has been expanding globally.

Global Tissue Imaging Market Challenge:

High Cost & Lack of Trained Professionals to Pose Challenge to the Global Tissue Imaging Market– Despite the broad diagnostic & research applications of tissue imaging technologies, the high cost of products like Mass Spectroscopy Imaging (MSI) Platforms, In-Situ Hybridization Platforms, and Flow Cytometers among others have been limiting their adoption. These products typically range from USD75,000 to USD 100,000 which limits the end users to only selected medical facilities in countries like India, China, Brazil Africa, Vietnam, etc., to afford it. Even for facilities that afford it, the maintenance and repair costs remain high. This ultimately leads to high charges for diagnostic tests, making it unaffordable for patients who then opt for less costly alternatives, thereby affecting the demand for these technologies. Research facilities too with limited funds cannot afford such costly products, which not only affects the market growth but also restricts them from conducting quality research.

Additionally, such technologies require proper expertise to handle and utilize them for diagnostic & research purposes. However, not enough trained professionals are there, especially in low-resource settings. This further impacts the market growth by limiting facilities to procure such advanced technologies in the absence of the right personnel to manage them.

Global Tissue Imaging Market (2025-30): Segmentation Analysis

The Global Tissue Imaging study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2025–2030 at the global levels. Based on the analysis, the market has been further classified as:

Based on the Technology:

• Mass Spectroscopy
  • MALDI Imaging
  • DESI Imaging
  • SIMS Imaging
• Immunohistochemistry (IHC)
• Flow Cytometry
• Digital Pathology
• In Situ Hybridization (ISH)
  • Fluorescence In-Situ Hybridization (FISH)
    • DNA Fluorescence In-Situ Hybridization
    • RNA Fluorescence In-Situ Hybridization
    • Protein Fluorescence In-Situ Hybridization
  • Chromogenic In-Situ Hybridization (CISH)
• Immunofluorescence
  • Indirect Immunofluorescence (Secondary)
  • Direct Immunofluorescence (Primary)
• Others (Confocal Microscopy, Electron Microscopy, etc.)

The Flow Cytometry segment had a considerable market share in the Global Tissue Imaging Market in 2025. The high rates of diseases like cancer & HIV have necessitated the adoption of flow cytometry technologies to effectively monitor & treat diseases. For instance, as stated by the WHO, in 2023 about 39.9 million patients had HIV globally.

Further, increasing support from government authorities in the form of investments & funding has accelerated biomedical research in countries like the UK, Germany, India, etc. This has allowed research institutions to adopt technologies like flow cytometry for quality research. For example, in 2023, the UK’s National Institute for Health and Care announced funding of USD118.6 million to encourage research projects across England.

Moreover, technological advancements such as the integration of Artificial Intelligence (AI), automation, smaller sizes, software-guided tools, etc. have enhanced the diagnostic & research capabilities of flow cytometry. As a result, the adoption of these technologies has witnessed a rise across healthcare & research facilities around the world. Hence, considering the mentioned factors, the flow cytometry category’s market size will be expanding in the coming years as well.

Based on the End User:

• Hospitals and Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

Hospitals and Diagnostic laboratories have held a prominent share in the Global Tissue Imaging Market in 2025. This has been because hospitals & diagnostic laboratories being the major healthcare facilities are visited by patients suffering from a range of health conditions including Alzheimer’s & cancer, who get effective diagnoses via tissue imaging technologies. 

Further, in recent years, across nations, attributed to the increasing patient population, boost in medical tourism, etc. there has been significant progress in the development of private hospitals & diagnostic laboratories. As a result, the demand for tissue imaging technologies like flow cytometry, mass spectroscopy, etc. by these hospitals has increased. For instance,

• In 2024, SRM Global Hospitals based in Chennai, India introduced an X-ray-free 3-D model-based imaging system based on advanced non-fluoroscopic mapping technology to help doctors effectively diagnose the sources of irregular heart rhythms.

Also, efforts have been made by governments across countries to boost the healthcare infrastructure of their country. This resulted in investments in new public hospital construction and upgrades in existing facilities through the adoption of advanced healthcare technologies & products like tissue imaging. Hence, owing to the factors mentioned, the hospitals & diagnostic laboratories category has been experiencing considerable growth.

Global Tissue Imaging Market (2025-30): Regional Projection

Geographically, the Global Tissue Imaging Market expands across:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia Pacific

North America is anticipated to hold the highest market share among all the regions in 2030. This would be led primarily by the large elderly population which is translating into higher neurological diseases such as Alzheimer's and Parkinson’s. This is projected to increase the adoption of tissue imaging products in the US, Canada & Mexico's healthcare facilities, allowing for improved diagnosis and disease monitoring for patients. For instance,

• The Alzheimer’s Association mentioned that in 2024, about 6.9 million Americans aged 65 and above are living with Alzheimer’s disease.

Additionally, research institutions have been conducting programs to better understand these diseases and develop new treatments, leading to a higher demand for tissue imaging technologies. Government support and funding for neurological research programs have further boosted the market for tissue imaging in the region. For instance,

• In 2024, Canada's government announced funding of USD80 million for Brain Canada’s research programs to improve brain health.

Moreover, countries including the US & Mexico have a highly developed healthcare ecosystem with healthcare providers continuously seeking state of art advanced healthcare technologies like tissue imaging to improve patient health outcomes.

Global Tissue Imaging Market Recent Development:

• 2024: Roche Holding AG received the US FDA clearance for its whole-slide imaging system, the Roche Digital Pathology Dx, for use as an aid in clinical diagnosis. This system would help pathologists review and interpret digital images of scanned pathology slides.
• 2024: Bio-Rad launched ChemiDoc Go Imaging System for highly sensitive benchtop gel and Western blot imaging.

Gain a Competitive Edge with Our Global Tissue Imaging Market Report

• Global Tissue Imaging Market Report by MarkNtel Advisors provides a detailed & thorough market analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• Global Tissue Imaging Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.